No One Should Edit The Genes Of Embryos To Make Babies, NIH Chief Says
By Nidhi Subbaraman,
BuzzFeed
| 07. 14. 2016
[originally published as "At Gene Editing Meeting, Scientists Discuss God, Racism, Designer Babies"]
Gene editing must never be used to create “designer babies” with enhanced abilities, the director of the National Institutes of Health (NIH) told a gathering of top scientists on Tuesday.
More provocatively, he also said that science is not ready for the controversial new technology to be used to eliminate genetic diseases that are passed down from one generation to the next.
“We must be aware of the hubris that it would take for human beings to be so smart that we thought we had the ability and the ethical principles to do such a thing,” the NIH chief, Francis Collins, said. “Humility would be a very good principle to attach to any such discussion.”
Collins was addressing a prestigious committee of about two dozen legal and scientific experts gathered to discuss the ethics of gene editing — a new technology that grabbed the spotlight last year.
CRISPR/Cas9, the most famous of this suite of powerful new tools, enables scientists to locate and replace human genes with unprecedented ease and precision.
But the prospect of using the tool on egg...
Related Articles
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
